Beneficial Effects of Flavonoids Against Parkinson's Disease
Parkinson's disease (PD) is characterized by the progressive degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta and decreases in striatal dopamine levels. These changes led to several clinical symptoms: rigidity, resting tremor, and bradykinesia. Although the cause...
Saved in:
Published in | Journal of medicinal food |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
01.05.2018
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Parkinson's disease (PD) is characterized by the progressive degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta and decreases in striatal dopamine levels. These changes led to several clinical symptoms: rigidity, resting tremor, and bradykinesia. Although the cause of PD remains unclear, it is widely accepted that oxidative stress, neuroinflammation, mitochondrial dysfunction, and insufficient support of neurotrophic factors are involved in the pathophysiology of the disease. However, novel regimens to prevent neurodegeneration and restore the degenerated nigrostriatal DA system are still required. In recent years, there has been a growing interest in naturally occurring phytochemicals, which are believed to reduce the risk of neurodegenerative diseases. This review provides an overview of the scientific literature concerning the preventive and protective roles of flavonoids, one of the largest families of phytochemicals, against PD. In addition to providing antioxidant and anti-inflammatory effects, flavonoids exhibit a neuroprotective effect by activating antiapoptotic pathways that target mitochondrial dysfunction and induce neurotrophic factors. This review suggests that flavonoids may be promising natural products for the prevention of PD and could potentially be utilized as therapeutic compounds against PD, even though there was no report showing that the treatment with flavonoids could restore the aberrant phenotypes of patients with PD. |
---|---|
AbstractList | Parkinson's disease (PD) is characterized by the progressive degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta and decreases in striatal dopamine levels. These changes led to several clinical symptoms: rigidity, resting tremor, and bradykinesia. Although the cause of PD remains unclear, it is widely accepted that oxidative stress, neuroinflammation, mitochondrial dysfunction, and insufficient support of neurotrophic factors are involved in the pathophysiology of the disease. However, novel regimens to prevent neurodegeneration and restore the degenerated nigrostriatal DA system are still required. In recent years, there has been a growing interest in naturally occurring phytochemicals, which are believed to reduce the risk of neurodegenerative diseases. This review provides an overview of the scientific literature concerning the preventive and protective roles of flavonoids, one of the largest families of phytochemicals, against PD. In addition to providing antioxidant and anti-inflammatory effects, flavonoids exhibit a neuroprotective effect by activating antiapoptotic pathways that target mitochondrial dysfunction and induce neurotrophic factors. This review suggests that flavonoids may be promising natural products for the prevention of PD and could potentially be utilized as therapeutic compounds against PD, even though there was no report showing that the treatment with flavonoids could restore the aberrant phenotypes of patients with PD. |
Author | Jung, Un Ju Kim, Sang Ryong |
Author_xml | – sequence: 1 givenname: Un Ju surname: Jung fullname: Jung, Un Ju organization: 1 Department of Food Science and Nutrition, Pukyong National University , Busan, Korea – sequence: 2 givenname: Sang Ryong surname: Kim fullname: Kim, Sang Ryong organization: 3 Brain Science and Engineering Institute, Kyungpook National University , Daegu, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29412767$$D View this record in MEDLINE/PubMed |
BookMark | eNo1j0tLxDAUhYMozkOXbiU7V603aR4NuBnHGRUGdKHr4aZJJGObDk0V_PeOqKtzPjh8cGbkOPXJE3LBoGRQm-tdF0oOTJcCdH1EpkxKXWgFMCGznHcAUIlKn5IJN4JxrfSU3Nz65ENsIrZ0FYJvxkz7QNctfvapjy7TxRvGlEf6jMP7ofTpKtO7mD1mf0ZOArbZn__lnLyuVy_Lh2LzdP-4XGyKRnA1FoFLW6nADFobLNemRiWdsxZNY5loOCgTqkp4zT1DJg8guAMmndY_cz4nl7_e_YftvNvuh9jh8LX9v8G_AW-nSQE |
CitedBy_id | crossref_primary_10_1016_j_phyplu_2024_100558 crossref_primary_10_1016_j_lfs_2023_121995 crossref_primary_10_1016_j_neuint_2021_105135 crossref_primary_10_3390_chemosensors9100280 crossref_primary_10_1016_j_dscb_2022_100049 crossref_primary_10_3923_ijp_2024_942_955 crossref_primary_10_26599_FSHW_2022_9250035 crossref_primary_10_2174_1568026620666200416085330 crossref_primary_10_3390_biom12030371 crossref_primary_10_3390_ijms24076328 crossref_primary_10_1080_1028415X_2022_2073107 crossref_primary_10_29328_journal_jnnd_1001026 crossref_primary_10_62313_ijpbp_2022_22 crossref_primary_10_1007_s11011_020_00568_5 crossref_primary_10_2174_1871527320666210129122033 crossref_primary_10_2174_2210315512666220520150358 crossref_primary_10_3390_biom9070271 crossref_primary_10_3390_antiox13111364 crossref_primary_10_3390_ijms25021071 crossref_primary_10_5115_acb_19_119 crossref_primary_10_1007_s11011_022_01032_2 crossref_primary_10_1021_acschemneuro_1c00285 crossref_primary_10_4103_1673_5374_300461 crossref_primary_10_1016_j_ejmech_2025_117401 crossref_primary_10_1021_acsmedchemlett_3c00573 crossref_primary_10_1155_2022_5262677 crossref_primary_10_3390_ijms232012289 crossref_primary_10_7759_cureus_10921 crossref_primary_10_3390_ijms222111484 crossref_primary_10_1016_j_fitote_2024_106086 crossref_primary_10_11620_IJOB_2020_45_2_33 crossref_primary_10_3389_fphys_2023_1216948 crossref_primary_10_3389_fnagi_2020_00209 crossref_primary_10_3390_antiox12020280 crossref_primary_10_3390_antiox9070609 crossref_primary_10_3390_ijms21228653 crossref_primary_10_1080_87559129_2020_1721530 crossref_primary_10_1093_advances_nmaa112 crossref_primary_10_3390_antiox12030663 crossref_primary_10_1016_j_neuint_2019_104612 crossref_primary_10_4103_1673_5374_306082 crossref_primary_10_2174_1573401315666190801120306 crossref_primary_10_3390_antiox10020142 crossref_primary_10_3390_nu10050642 crossref_primary_10_1016_j_biopha_2023_115788 crossref_primary_10_3390_ijms22073338 crossref_primary_10_1016_j_jff_2021_104609 crossref_primary_10_3390_antiox13060645 crossref_primary_10_2174_0115680266303704240524080333 crossref_primary_10_1007_s00210_024_03462_4 crossref_primary_10_2174_1874609815666220819145845 crossref_primary_10_1111_jfbc_14426 crossref_primary_10_3390_molecules28052081 crossref_primary_10_1080_14737175_2021_1923479 crossref_primary_10_1093_nutrit_nuae079 crossref_primary_10_3390_antiox12071463 crossref_primary_10_1007_s13346_023_01407_7 crossref_primary_10_1016_j_intimp_2023_109698 crossref_primary_10_1002_cbf_3964 crossref_primary_10_1016_j_phanu_2020_100226 crossref_primary_10_3390_ijms22062953 crossref_primary_10_1016_j_neuroscience_2025_02_007 crossref_primary_10_2174_0118715249264078231214074107 crossref_primary_10_3390_neurolint16050082 crossref_primary_10_1080_10408398_2023_2299340 crossref_primary_10_3389_fphar_2024_1507108 crossref_primary_10_1016_j_bmcl_2024_129618 crossref_primary_10_1021_acschemneuro_2c00726 crossref_primary_10_1111_cns_13053 crossref_primary_10_3390_ijms24087318 crossref_primary_10_1111_cbdd_14619 crossref_primary_10_1016_j_cbi_2019_02_027 crossref_primary_10_1016_j_ejmech_2019_111862 crossref_primary_10_1016_j_ijbiomac_2019_09_148 crossref_primary_10_4103_1673_5374_301010 crossref_primary_10_3390_ijms21103624 crossref_primary_10_1080_10408398_2023_2171960 crossref_primary_10_4103_ejpi_EJPI_D_24_00083 crossref_primary_10_3389_fnins_2023_1153889 crossref_primary_10_1515_jcim_2018_0233 crossref_primary_10_1016_j_neuint_2019_104514 crossref_primary_10_1016_j_neuro_2022_03_004 crossref_primary_10_1007_s00109_021_02071_5 crossref_primary_10_2174_1570159X19666210524152817 crossref_primary_10_3390_antiox9070583 crossref_primary_10_3390_foods13121931 crossref_primary_10_3390_agriculture14020296 crossref_primary_10_1016_j_cclet_2024_110784 crossref_primary_10_1016_j_cbpc_2022_109500 crossref_primary_10_3390_molecules25071715 crossref_primary_10_3390_ijms23073625 crossref_primary_10_1016_j_neuro_2024_02_006 crossref_primary_10_1242_jeb_244556 crossref_primary_10_1016_j_clnesp_2022_01_023 crossref_primary_10_3390_molecules28062536 |
ContentType | Journal Article |
DBID | NPM |
DOI | 10.1089/jmf.2017.4078 |
DatabaseName | PubMed |
DatabaseTitle | PubMed |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine Economics Diet & Clinical Nutrition |
EISSN | 1557-7600 |
ExternalDocumentID | 29412767 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 29L 4.4 53G 5GY 9ZL AAHBH AAWTL ABBKN ABJNI ACGFS ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS BNQNF CS3 EBS EJD F5P IAO ICU IHR IM4 INH MV1 NPM NQHIM O9- P2P RML UE5 ~KM |
ID | FETCH-LOGICAL-c426t-f25b36f19abbfb2798a65ddbba9cb14c2069f334e72e1a159f342d015d77b2792 |
IngestDate | Thu Apr 03 08:16:55 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | flavonoids neuroprotection Parkinson's disease |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c426t-f25b36f19abbfb2798a65ddbba9cb14c2069f334e72e1a159f342d015d77b2792 |
PMID | 29412767 |
ParticipantIDs | pubmed_primary_29412767 |
PublicationCentury | 2000 |
PublicationDate | 2018-05-01 |
PublicationDateYYYYMMDD | 2018-05-01 |
PublicationDate_xml | – month: 05 year: 2018 text: 2018-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of medicinal food |
PublicationTitleAlternate | J Med Food |
PublicationYear | 2018 |
SSID | ssj0003437 |
Score | 2.4909947 |
SecondaryResourceType | review_article |
Snippet | Parkinson's disease (PD) is characterized by the progressive degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta and decreases in... |
SourceID | pubmed |
SourceType | Index Database |
Title | Beneficial Effects of Flavonoids Against Parkinson's Disease |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29412767 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS-QwEA9-gPoiup7fSh5EH5au2yRtWvDFT0TQJxd8k6RJjhW3Fdo7uPvrnbSzWz-P05dQkrSE-TXJJDPzG0L2IutcYmIVWKl4IFIbB9pKHYAy7niScaVrio3rm_hyIK7uors2Z2YdXVLpXvb3w7iS76AKdYCrj5L9ArKTj0IFPAO-UALCUP4XxiewUCEDxHnrl3HxqH4XeTE0Zff4Jxz8y6rrY5sxzEuWnnFzYpR5r5eitb0ObCzMxMMGF4VB3r361RruR82tsnfh-1PgJoh3CGHSeuz1LK57kQy8je7DVbWfeFLSh1FNeSp73vT3sh8I5WlUi5ilImSyya_x79Y3JNfjpmkyDeq-z1_qL11wQ-WCS6RHhZEcvhqHJ3PGd98cDGoF4XaJLKIE6XED0zKZsnmHbJwNbUX3KdKvPtKbcfaDDpkfB4WXHTJ3jT4OK-SoRZUiqrRwtEWVIqp0gupBSRHTH2RwcX57ehlgjosgA92oChyLNI9dmCqtnWYyTVQcGaO1SjMdioz1Y5g0XFjJbKhA93RcMAM6nJHSd2erZCYvcrtOqEiY4mFmtBBSGONSzTOVKun6IjROuA2y1sjn_qkhMrkfS27z05YtstD-L9tk1sHMsTughlV6twbpGW_DMDY |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Beneficial+Effects+of+Flavonoids+Against+Parkinson%27s+Disease&rft.jtitle=Journal+of+medicinal+food&rft.au=Jung%2C+Un+Ju&rft.au=Kim%2C+Sang+Ryong&rft.date=2018-05-01&rft.eissn=1557-7600&rft_id=info:doi/10.1089%2Fjmf.2017.4078&rft_id=info%3Apmid%2F29412767&rft_id=info%3Apmid%2F29412767&rft.externalDocID=29412767 |